(firstQuint)Observational Study Evaluating the Safety of ADASUVE in Agitation Associated With Schizophrenia or Bipolar I Disorder.

 This is a multicenter, prospective, observational study conducted to evaluate the safety of ADASUVE treatment when used in real-world clinical setting in patients with agitation associated with schizophrenia or bipolar I disorder.

 The primary objective of the study is to assess the safety of ADASUVE treatment in real-world clinical settings.

 The secondary objective of the study is to describe the characteristics of patients, including demographic and baseline characteristics, after administration of ADASUVE treatment in real-world clinical settings.

 The study population will consist of a non-randomized cohort of approximately 10000 adult men and women who have agitation associated with schizophrenia or bipolar I disorder (naive and non-naive to ADASUVE treatment).

.

 Observational Study Evaluating the Safety of ADASUVE in Agitation Associated With Schizophrenia or Bipolar I Disorder@highlight

This postmarketing observational study will evaluate the safety of ADASUVE(R) in treating patients with agitation associated with schizophrenia or bipolar I disorder.

